A Letter from the Editor  by Kaul, Karen L.
Editorial
A Letter from the Editor
Molecular diagnostics is an ever-evolving field, and sim-
ilarly The Journal of Molecular Diagnostics is continuing to
grow and change. You may have noticed that we have
increased the frequency of publication, and each issue is
more interesting and full than ever before. Now in our
seventh year, we look forward to bringing you even better
content and expanded services.
Although JMD is evolving, our emphasis remains the
publication of high-quality, clinically relevant research
focusing on the translation of molecular science into the
clinical diagnostic setting. Because our field has grown,
we are now including studies applicable to the diagnosis,
monitoring, prognostic determination, and characteriza-
tion of solid and hematological tumors, genetic diseases,
infectious diseases, and other areas, and using a range
of approaches including the analysis of nucleic acids and
proteins. Pharmacogenetics is beginning to make its way
into our clinical practice, and proteomic approaches are
on our horizon. We welcome submissions in these bur-
geoning fields of study as they apply to molecular diag-
nostics. Additionally, the JMD is including more articles
describing studies and techniques that, while not yet
ready for clinical application, will keep our readership
appraised of new approaches, targets, and trends before
they become routine.
With this issue, you will notice the addition of a
Technical Advance article category. This new section
of the JMD is intended to report groundbreaking new
approaches and technologies that will be important in
our field. This month, we feature three such studies,
each of which describes a novel approach that will
enable labs to more accurately and rapidly analyze
nucleic acids from samples. The first article reports the
use of a novel aluminum oxide tube in which nucleic
acids can be rapidly isolated and amplified. The sec-
ond reports and validates the application of a whole
genome amplification method to facilitate analysis of
DNA in plasma samples, an exciting new approach for
the diagnosis of many different diseases. The third
Technical Advance examines the performance and re-
liability of gene expression signatures measured in
tissues collected in RNA preserving solution, an impor-
tant issue as we try to apply expression-based analysis
to human tissues collected in pathology.
Additionally, the JMD will soon be featuring commen-
taries to highlight some of the key articles in that current
issue of the Journal. Commentaries will be designed to
provide background and context, highlight controversies,
and emphasize the importance of the articles they ac-
company. We will also be bringing you more reviews and
minireviews in future issues. The quality and breadth you
have come to expect of original research articles in the
JMD will remain unchanged. In addition to regular arti-
cles, each issue will continue to feature the now-familiar
Consultations in Molecular Diagnostics. Consultations
are short, case-oriented reports meant to illustrate a clas-
sic or novel application of a molecular diagnostic ap-
proach, a unique observation, interpretive challenge, or
technical issue. These will continue to hold great teach-
ing value for those of us practicing molecular diagnostics
in the clinical setting.
As quickly as our field evolves, it is ever more im-
portant to disseminate published research quickly,
broadly, and responsibly. To that end, we are proud to
announce the inauguration of JMDXpress, our online
prepublication program that will allow readers to view
preprint versions of articles on the Journal’s website
shortly after the acceptance date, rather than weeks
later in the printed Journal. While not the final version of
these articles, papers featured on JMDXpress will have
already gone through the rigorous peer-review and
first-pass copyediting stage of publication preparation,
and will enable readers to get a first look at research on
the horizon.
Additionally, we are pleased to announce our new
affiliation with PubMed Central (PMC), which will allow
research published in the JMD to reach an even
greater audience. Once published articles are made
freely available at the JMD website (12 months after
publication), article content will also be accessible
through the PMC repository. Additionally, our affiliation
with PMC should allow us to better assist our authors in
cooperating with the National Institutes of Health’s
Public Access to Research Initiative, announced in
May 2005. Through this affiliation, the JMD Editorial
Office will submit articles to PMC (again, to be made
publicly available at 12 months after print publication)
on behalf of authors whose articles have been funded
by the National Institutes of Health.
In collaboration with the Association for Molecular Pa-
thology and the American Society for Investigative Pa-
thology, the JMD is implementing a continuing medical
education (CME) program. The JMD CME Program in
Molecular Diagnostics, which is accredited for 50 CME
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credits annually, shares the same basic educational
goals as the Journal itself: to help readers grasp the latest
advances in understanding the molecular pathogenesis
of disease, to learn about new technological advances in
molecular diagnosis, and to become familiar with the
complexities of diagnostic and prognostic approaches to
disease. Beginning this month, each issue will contain
articles selected for their particular educational value to
the molecular diagnostics community. (A triangular flag in
the Table of Contents indicates these articles.) Questions
pertaining to these articles are provided in both the print
and online versions of the JMD. See the back of this issue
for the first set of questions. We hope that you will find
these exercises useful, not only for earning CME credit,
but also as a basic educational resource for you, your
students, residents and fellows, and your laboratory staff.
We continue to look for ways in which we can add
value to both your experience of the JMD and to the
molecular diagnostics community as a whole. Through
the continued efforts and commitment of our authors,
Editorial Board, and readership, the JMD is growing and
evolving. We hope you will find these new programs and
features useful, and look forward with enthusiasm to the
future of The Journal of Molecular Diagnostics.
Karen L. Kaul, M.D., Ph.D.
Editor-in-Chief
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